Trial intelligence / Profile preview

Budesonide for MPA-Induced Diarrhea in Renal Transplant

NCT02991768Phase 2Terminated

Sponsor
University of Kansas Medical Center
Start
Jan 2017
Primary completion
Apr 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of budesonide in diarrhea, sponsored by University of Kansas Medical Center. Started Jan 2017; status: terminated.

02

Drugs

budesonide
03

Conditions

diarrhea

Beyond the preview

Go deeper on NCT02991768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02991768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call